EP1845985A4 - Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer - Google Patents

Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer

Info

Publication number
EP1845985A4
EP1845985A4 EP06734275A EP06734275A EP1845985A4 EP 1845985 A4 EP1845985 A4 EP 1845985A4 EP 06734275 A EP06734275 A EP 06734275A EP 06734275 A EP06734275 A EP 06734275A EP 1845985 A4 EP1845985 A4 EP 1845985A4
Authority
EP
European Patent Office
Prior art keywords
etiology
cancer
treatment
methods
viral infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06734275A
Other languages
German (de)
French (fr)
Other versions
EP1845985A2 (en
Inventor
Vladimir Khazak
Erica A Golemis
Sanjay R Menon
Lutz Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fox Chase Cancer Center
NexusPharma Inc
Original Assignee
Fox Chase Cancer Center
NexusPharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Center, NexusPharma Inc filed Critical Fox Chase Cancer Center
Publication of EP1845985A2 publication Critical patent/EP1845985A2/en
Publication of EP1845985A4 publication Critical patent/EP1845985A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP06734275A 2005-02-02 2006-02-02 Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer Withdrawn EP1845985A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64947005P 2005-02-02 2005-02-02
PCT/US2006/003817 WO2006084116A2 (en) 2005-02-02 2006-02-02 Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer

Publications (2)

Publication Number Publication Date
EP1845985A2 EP1845985A2 (en) 2007-10-24
EP1845985A4 true EP1845985A4 (en) 2011-10-12

Family

ID=36777960

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06734275A Withdrawn EP1845985A4 (en) 2005-02-02 2006-02-02 Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer

Country Status (5)

Country Link
EP (1) EP1845985A4 (en)
JP (1) JP2008528697A (en)
AU (1) AU2006210537A1 (en)
CA (1) CA2596799A1 (en)
WO (1) WO2006084116A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926297B1 (en) 2008-01-10 2013-03-08 Centre Nat Rech Scient INHIBITORY CHEMICAL MOLECULES IN THE SPLICE MECHANISM FOR TREATING DISEASES RESULTING FROM SPLICE ANOMALIES.
EP2262527B1 (en) 2008-02-29 2016-08-03 Acorda Therapeutics, Inc. Compositions for achieving desired glial growth factor 2 plasma levels
EP2505198A1 (en) 2011-04-01 2012-10-03 Société Splicos Compounds for use as therapeutic agents affecting p53 expression and/or activity

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369226B1 (en) * 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease
WO2003037865A1 (en) * 2001-10-31 2003-05-08 Morphochem Aktiengesellschaft für kombinatorische Chemie Novel anticancer compounds
US20030229053A1 (en) * 2001-06-11 2003-12-11 Shire Biochem Inc. Compounds and methods for the treatment or prevention of flavivirus infections
WO2004043913A2 (en) * 2002-11-08 2004-05-27 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof
US6750348B1 (en) * 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750348B1 (en) * 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
US6369226B1 (en) * 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease
US20030229053A1 (en) * 2001-06-11 2003-12-11 Shire Biochem Inc. Compounds and methods for the treatment or prevention of flavivirus infections
WO2003037865A1 (en) * 2001-10-31 2003-05-08 Morphochem Aktiengesellschaft für kombinatorische Chemie Novel anticancer compounds
WO2004043913A2 (en) * 2002-11-08 2004-05-27 Trimeris, Inc. Hetero-substituted benzimidazole compounds and antiviral uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARKUS MENGES: "Kaposi's Sarcoma of the Pancreas Mimicking Pancreatic Cancer in an HIV-Infected Patient: Clinical Diagnosis by Detection of HHV 8 in Bile and Complete Remission Following Antiviral and Cytostatic Therapy with Paclitaxel", INTERNATIONAL JOURNAL OF GASTROINTESTINAL CANCER, vol. 26, no. 3, 1 January 1999 (1999-01-01), pages 193 - 200, XP055005971, ISSN: 1537-3649, DOI: 10.1385/IJGC:26:3:193 *

Also Published As

Publication number Publication date
WO2006084116A2 (en) 2006-08-10
WO2006084116A3 (en) 2007-06-07
EP1845985A2 (en) 2007-10-24
AU2006210537A1 (en) 2006-08-10
JP2008528697A (en) 2008-07-31
CA2596799A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
IL257622B (en) Methods and compositions for the treatment of persistent infections
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
ZA200904492B (en) Compositions and methods for the treatment of infections and tumors
IL186808A0 (en) Topiramate compositions for treatment of headache
IL195272A0 (en) Methods and compositions for the treatment of viral infections
IL184242A0 (en) Indole derivatives for treating viral infections
ZA201100176B (en) Compounds and pharmaceutical compositions for the treatment of viral infections
SG10201508623RA (en) Crystals of laquinimod sodium, and process for the manufacture thereof
IL197804A0 (en) Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c
EP1893625A4 (en) Methods for the preparation of 9-deazapurine derivatives
IL218351A0 (en) Process for the preparation of amines
IL190466A0 (en) Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis
EP1904088A4 (en) Compositions and methods for the treatment of cancer
EP1901752A4 (en) Compositions and methods for viral inhibition
EP1845985A4 (en) Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer
IL188831A0 (en) Compositions for reducing the incidence of drug induced arrhythmia
HUE026600T2 (en) Compositions and methods for the treatment of viral hepatitis
PL1951374T3 (en) Treatment of sub-gingival pocket infections
HUP0500947A2 (en) Composition for treatment of paradontosis
ZA200706203B (en) Processes and compounds for the preparation of substituted naphthylindole derivatives
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
ZA200800201B (en) Composition and the use thereof for the treatment of viral infections
PL376876A1 (en) Pharmaceutical compounds for auxiliary treatment of bird infections
IL166800A0 (en) Compositions for separating and crystallizing of molecules

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070821

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/44 20060101ALI20071120BHEP

Ipc: A61K 31/435 20060101AFI20071120BHEP

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WEBER, LUTZ

Inventor name: MENON, SANJAY, R.

Inventor name: GOLEMIS, ERICA, A.

Inventor name: KHAZAK, VLADIMIR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20110909

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4402 20060101ALI20110905BHEP

Ipc: A61P 31/22 20060101ALI20110905BHEP

Ipc: A61P 31/20 20060101ALI20110905BHEP

Ipc: A61K 31/44 20060101ALI20110905BHEP

Ipc: A61K 31/435 20060101AFI20110905BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120411